Wellcome Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $375M | Hold |
4,800,000
| – | – | 4.33% | 11 |
|
|
2025
Q1 | $348M | Hold |
4,800,000
| – | – | 4.35% | 10 |
|
|
2024
Q4 | $355M | Buy |
4,800,000
+300,000
| +7% | +$22.2M | 4.29% | 10 |
|
|
2024
Q3 | $297M | Buy |
4,500,000
+400,000
| +10% | +$26.4M | 3.62% | 16 |
|
|
2024
Q2 | $379M | Hold |
4,100,000
| – | – | 4.84% | 9 |
|
|
2024
Q1 | $392M | Hold |
4,100,000
| – | – | 4.71% | 8 |
|
|
2023
Q4 | $313M | Buy |
4,100,000
+590,000
| +17% | +$45M | 3.87% | 13 |
|
|
2023
Q3 | $243M | Buy |
3,510,000
+2,860,000
| +440% | +$198M | 3.23% | 17 |
|
|
2023
Q2 | $61.3M | Hold |
650,000
| – | – | 0.81% | 21 |
|
|
2023
Q1 | $53.8M | Hold |
650,000
| – | – | 0.75% | 21 |
|
|
2022
Q4 | $48.5M | Buy |
650,000
+325,000
| +100% | +$24.2M | 0.72% | 22 |
|
|
2022
Q3 | $26.9M | Buy |
+325,000
| New | +$26.9M | 0.42% | 22 |
|